Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
The Annals of Occupational Hygiene
|
March 1, 2005
Evaluation of an artificial intelligence program for estimating occupational exposures
Karen L Johnston, Margaret L Phillips, Nurtan A Esmen, et al.
The International Journal of Neuropsychopharmacology
|
February 1, 2024
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations
Ibrahim Turkoz, Mehmet Daskiran, Uzma Siddiqui, et al.
CNS Spectrums
|
November 8, 2024
Comparing two transitioning strategies to paliperidone palmitate once-every-6-months
Christoph U Correll, Karen L Johnston, Ibrahim Turkoz, et al.
CNS Spectrums
|
December 5, 2024
Comparing two transitioning strategies to paliperidone palmitate once-every-6-months - ERRATUM
Christoph U Correll, Karen L Johnston, Ibrahim Turkoz, et al.
Neuropsychiatric Disease and Treatment
|
June 23, 2025
Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis
Joshua M Hamilton, Karen L Johnston, James Simples Jnr, et al.
The Journal of Clinical Psychiatry
|
September 27, 2023
Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis
Oliver J Lopena, Larry D Alphs, Martha Sajatovic, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
The Annals of Occupational Hygiene
|
March 1, 2005
Evaluation of an artificial intelligence program for estimating occupational exposures
Karen L Johnston, Margaret L Phillips, Nurtan A Esmen, et al.
The International Journal of Neuropsychopharmacology
|
February 1, 2024
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations
Ibrahim Turkoz, Mehmet Daskiran, Uzma Siddiqui, et al.
CNS Spectrums
|
November 8, 2024
Comparing two transitioning strategies to paliperidone palmitate once-every-6-months
Christoph U Correll, Karen L Johnston, Ibrahim Turkoz, et al.
CNS Spectrums
|
December 5, 2024
Comparing two transitioning strategies to paliperidone palmitate once-every-6-months - ERRATUM
Christoph U Correll, Karen L Johnston, Ibrahim Turkoz, et al.
Neuropsychiatric Disease and Treatment
|
June 23, 2025
Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis
Joshua M Hamilton, Karen L Johnston, James Simples Jnr, et al.
The Journal of Clinical Psychiatry
|
September 27, 2023
Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis
Oliver J Lopena, Larry D Alphs, Martha Sajatovic, et al.
Page
of 1